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Background. Exophiala species are mostly responsible for skin infections. Invasive Exophiala dermatitidis disease
is a rare and frequently fatal infection, with 42 cases reported. About half of these cases had no known risk factors.
Similarly, invasive Exophiala spinifera disease is extremely rare, with only 3 cases reported, all in patients with no
known immunodeficiency. Autosomal recessive CARD9 deficiency has recently been reported in otherwise healthy
patients with severe fungal diseases caused by Candida species, dermatophytes, or Phialophora verrucosa.
Methods. We investigated an8-year-old girl fromanonconsanguineousAngolan kindred,whowas born in France
and developed disseminated E. dermatitidis disease and a 26 year-old woman from an Iranian consaguineous kin-
dred, who was living in Iran and developed disseminated E. spinifera disease. Both patients were otherwise healthy.
Results. We sequenced CARD9 and found both patients to be homozygous for loss-of-function mutations
(R18W and E323del). The first patient had segmental uniparental disomy of chromosome 9, carrying 2 copies of
the maternal CARD9 mutated allele.
Conclusions. These are the first 2 patients with inherited CARD9 deficiency and invasive Exophiala disease to be
described. CARD9 deficiency should thus be considered in patients with unexplained invasive Exophiala species dis-
ease, even in the absence of other infections.
Keywords. Exophiala species; invasive fungal infection; central nervous system; osteomyelitis; autosomal
recessive CARD9 deficiency; parental unidisomy.
Exophiala dermatitidis, previously known as Wangiella
dermatitidis, is an environmental black yeast [1, 2]. In
Western countries, E. dermatitidis has been reported
to colonize the respiratory tract of about 6% of
patients with cystic fibrosis [3] and to be present in
the stools of 0.5% of patients with diarrhea [4]. By con-
trast, invasive E. dermatitidis disease (ie, noncontiguous
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extracutaneous localization) is rare. Since 1959, only 42 cases
have been reported worldwide, and for 23, no risk factors
were identified (Table 1) [5–18]. Exophiala spinifera is rare,
representing 2.7% of the Exophiala species among clinical
isolates [1, 2]. Only 29 cases of E. spinifera diseases have been
reported in the literature [19–24]). Only 3 patients, none of
whom had any known risk factors, had invasive infection (ie,
noncontiguous extra cutaneous localization) [13, 23, 24]. We
describe 2 patients with isolated, unexplained invasive fungal dis-
ease caused by E. dermatitidis or E. spinifera. Because autosomal
recessive (AR) CARD9 deficiency has recently been reported in 30
otherwise healthy patients from Iran, North Africa, Asia, and
Canada with invasive fungal diseases [25–29], we sequenced
CARD9 in the patients.
CASE SUMMARY
The first patient studied was an 8-year-old girl (Figure 1A) born
in France to nonconsanguineous parents originating from An-
gola. At the age of 5 years, she developed liver and brain E. der-
matitidis infection (Figure 1B and 1C). E. dermatitidis grew in
cultures and was identified on the basis of its phenotype, and
this identification was confirmed by internal transcribed spacer
(ITS) sequencing. Her case report is detailed in the Supplemen-
tary Materials. The patient was treated by irrigation of the bili-
ary tract with amphotericin B, a high intravenous dose of
liposomal amphotericin B, and oral voriconazole. A favorable
outcome was achieved, but despite this antifungal maintenance
treatment, the patient developed E. dermatitidis pachymeningi-
tis (Figure 1D and Figure 2A–D). This patient had never had
any other severe infectious disease. In addition, neither her par-
ents nor her 2 older brothers, aged 13 and 16 years, had had any
severe infectious disease.
Identification of a Homozygous CARD9 Missense Mutation
The coding exons of CARD9 were sequenced by the Sanger
method. Patient 1 displayed a homozygous c.52C > T missense
mutation in exon 2 of this gene, resulting in the replacement of
the arginine in position 18 with a tryptophan residue (R18W),
located in the N-terminal caspase-recruitment domain
(CARD). The patient’s healthy mother and her 2 brothers
were heterozygous for the mutation (WT/R18W; Figure 1A).
The patient’s father could not be tested. An Affymetrix ge-
nome-wide human SNP Array 6.0 analysis combined to a
CGH array analysis (Supplementary Materials) of the patient’s
DNA demonstrated that the patient had a segmental uniparen-
tal disomy (UPD) of chromosome 9, resulting in the carriage of
2 copies of the maternal CARD9 allele. The segregation of the
mutation was consistent with AR CARD9 deficiency and com-
plete clinical penetrance. The mutation reported here was not
found in any of the various public databases or in any of the
controls sequenced (Supplementary Materials). This mutation
was predicted to be probably damaging (with the highest possi-
ble score of 1), by PolyPhen 2, and as damaging, by SIFT (with a
score of 0). Collectively, these data strongly suggested that the
patient was homozygous for a rare, deleterious CARD9missense
mutation.
The R18W Mutant CARD9 Protein Is Produced but Has Lost Its
Function
We evaluated the consequences of the mutation at the CARD9
protein level, by Western blot analysis on whole-cell extracts of
HEK-293 T cells transfected with a pcDNA3.1 V5 (C-terminally
tagged) plasmid with no insert or carrying the WT or R18W
allele of CARD9 (pcDNA3.1 V5 CARD9 WT and pcDNA3.1
V5 CARD9 R18W). Cells transfected with the CARD9 R18W
allele had slightly higher CARD9 protein levels than those
transfected with the WT allele, and the protein detected was of
similar molecular weight (Figure 3A). Flow cytometry analysis
of CARD9 protein in monocytes (Supplementary Figure A) and
monocyte-derived macrophages (MDMs; Figure 3B) from the
patient showed that the levels of this protein were comparable
to those in monocytes and MDMs from a healthy control. We
evaluated the functional consequence of this mutation by study-
ing interleukin 6 (IL-6) production by whole-blood cells after
24 hours of stimulation with zymosan (an agonist of at least
Dectin-1 and Toll-like receptor 2), heat-killed Saccharomyces
cerevisiae, Candida albicans, E. dermatitidis, and Staphylococcus
aureus, vesicular stomatitis virus (VSV), lipopolysaccharide
(LPS; a TLR4 agonist), and PMA plus ionomycin. The cells
from patient 1 produced much smaller amounts of IL-6 after
stimulation with S. cerevisiae, E. dermatitidis, and, to a lesser ex-
tent, C. albicans, than cells from 6 healthy controls or the het-
erozygous mother tested in parallel (Figure 3C). The responses
to zymosan, LPS, S. aureus, VSV, and PMA plus ionomycin
were normal. We then assessed TNF-α production by mono-
cyte-derived dendritic cells (MDDCs) obtained from the patient
and 7 healthy controls and stimulated for 24 hours with curdlan
(a dectin-1 agonist) and the same agonists used in the whole-
blood assay (Figure 3D). The patient displayed a strong imp-
airment of TNF-α production after stimulation with all fungal
ligands used (curdlan, zymosan, heat-killed S. cerevisiae,
C. albicans, and E. dermatitidis), whereas TNF-α production
was similar to that in healthy controls after stimulation with
S. aureus and LPS. In addition, 293 HEK cells transfected
with the R18W CARD9 allele showed a strongly impaired
NF-κB transcriptional activity, as assessed by NF-κB–luciferase
reporter assays, compared with cells transfected with the WT
CARD9 allele, either at the basal level or after stimulation
with curdlan or E. dermatitidis (Figure 3E). Finally, we evalu-
ated the proportion of ex vivo interleukin 17A (IL-17A)–
producing T cells by flow cytometry, as low proportions of
IL-17 T cells have been reported in some CARD9-deficient
patients [25–27, 29]. No differences were observed between
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Table 1. Demographic and Clinical Characteristics of Patients With Invasive Exophiala dermatitidis Infection Described in Previous
Studies and the Patient Studied Here
Characteristic Age, y (Sex)
Location
Outcome (Time From
Diagnosis to Death, mo) ReferenceBrain Liver Other
Patients without known risk factors
Country of origin
South Korea 11 (F) No Yes No Death (14) [9]
South Korea 28 (M) Yes No No Death (0.5) [10]
Turkey 8 (M) No Yes LN Death (7) [17]
Turkey 24 (F) No Yes LN Cure [11]
China 3 (M) Yes No No Death (4) [12]
China 19 (F) Yes No LN Death (5) [13]
China 30 (F) Yes No No Death (0.1) [13]
China 3 (F) Yes No No Death (6) [13]
China 19 (F) Yes No LN Death (1) [8]
China 21 (F) No Yes LN Cure [7]
Japan 25 (F) No No Palate, LN Death (36) [6]
Japan 30 (F) Yes No LN Death (3) [6]
Japan 11 (M) No Yes LN, dig Death (ND) [6]
Japan 14 (F)a No Yes No Death (2) [6]
Japan 5 (F)a Yes No No Death (1) [6]
Japan NA (F) Yes No No Death (ND) [6]
Japan 26 (F) Yes No No Death (9) [6]
Japan 19 (M)a Yes Yes LN Death (2) [6]
Japan NA (M)a Yes Yes NA Death (ND) [6]
Japan 10 (M) Yes No Lung Death (11) [6]
Japan 20 (M) Yes No LN Death (NA) [6]
Japan 17 (M) Yes Yes LN Death (48) [6]
Pakistan 70 (M) Yes No No Death (0.5) [18]
Patients with predisposing factors other than PID
Predisposing factor
Contaminated steroid use 77 (F) Yes No No Death [5]
Contaminated steroid use 61 (F) Yes No No Cure [5]
Contaminated steroid use 71 (F) Yes No No ND [5]
Contaminated steroid use 65 (F) Yes No No ND [5]
Contaminated steroid use 52 (F) Yes No No ND [5]
Bronchiectasis 81 (M) No No Lung Cure [15]
Lung cancer, catheter use 58 (F) No No Blood Cure [5]
CAPD, catheter use 55 (M) No No Peritoneal Cure [5]
CAPD, catheter use 39 (M) No No Peritoneal Cure [5]
ALL 62 (F) No No LN Cure [5]
Cystic fibrosis 29 (F) No No Lung Cure [5]
Cystic fibrosis 6 (F) No No Lung Cure [5]
Cystic fibrosis 54 (F) No No Lung ND [5]
AIDS, catheter use 3 (M) No No Blood Cure [5]
Parenteral nutrition, catheter use 53 (F) No No Blood Cure [5]
ALL, catheter use 5 (M) No No Blood Cure [5]
Injection drug use 63 (M) No No Endocarditis Death [5]
Solid organ transplantation 50 (F) No No Endocarditis ND [5]
Patients with PID
CGD 21 (F) Yes No Lung Cure [14]
CARD9 deficiency 6 (F) Yes Yes No Relapse This report
Abbreviations: AIDS, acquired immunodeficiency syndrome; ALL, acute lymphoblastic leukemia; CAPD, continuous ambulatory peritoneal dialysis; CGD, chronic
granulomatous disease; dig, digestive tract; F, female; LN, lymph node; M, male; mo, months; NA, not available; ND, not determined; PID, primary
immunodeficiency disease.
a Multiplex family.
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the patient and the 7 healthy controls tested in parallel (Supple-
mentary Figure B). Furthermore, IL-17A production by whole-
blood cells after 24 hours of stimulation with PMA and
ionomycin, as measured by ELISA, was similar in the patient
and the 2 healthy controls tested in parallel (Supplementary
Figure B). We therefore conclude that the homozygous R18W
mutation led to the production of normal amounts of a loss-
of-function CARD9 protein, leading to the impairment of
proinflammatory cytokine production by whole-blood cells
and MDDCs after stimulation with various fungal ligands and
impairment of NF-κB transcriptional activity in transfected
HEK cells, whereas IL-17 T-cell production was normal.
Autosomal Recessive CARD9 Deficiency in Another Patient
With Invasive E. spinifera Infection
We recently studied a 26-year-old woman (Figure 4A) from an
Iranian consanguineous kindred living in Iran who presented
recurrent fungal infections from the age of 18 years onward,
with E. spinifera subcutaneous (Figure 4B), bone (Figure 4C),
and lung (Figure 4D) infection. E. spinifera grew in cultures
and was identified on the basis of its phenotype, and this
identification was confirmed by ITS sequencing. The case report
is detailed in the Supplementary Materials. The patient’s par-
ents and siblings were all healthy and had never had a severe
infectious fungal disease. The sequencing of CARD9 in the pa-
tient’s DNA showed a homozygous in-frame deletion, c.
GAG967-969del or p.E323del, located in the coiled-coil domain
of CARD9. This deletion was not found in any of the various
public databases or in any of the controls sequenced (Supple-
mentary Materials). Collectively, these data strongly suggest
that this patient is homozygous for a rare, deleterious CARD9
deletion mutation. Parental DNA testing was possible only for
the father, who was found to be heterozygous for the mutation.
DISCUSSION
We identified a homozygous R18W CARD9mutation in a child
with cholangitis and central nervous system (CNS) infection
caused by E. dermatitidis. We showed that this was a loss-
of-function mutation and that the child had functional CARD9
deficiency. The mutation was homozygous because of segmen-
tal UPD of the maternal chromosome 9q, which harbored the
Figure 1. A, Pedigree of the patient with Exophiala dermatitidis infection and a CARD9 mutation. Each generation is represented by a Roman numeral,
and each individual is represented by an Arabic numeral. The proband with E. dermatitidis infection is shown in black and indicated by an arrow. The CARD9
genotype is indicated below each individual. B–D, Radiological features of patient 1. B, Cholangio-magnetic resonance imaging showing a dilated and
irregular biliary tree with diffuse biliary duct infiltration. C, Brain magnetic resonance imaging (MRI) showing 13 cerebral lesions (diameter, 10–16 mm). D,
Brain MRI showing pachymeningitis and hydrocephalus. Abbreviation: WT, wild-type.
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mutant R18W CARD9 allele. The segmental UPD accounts for
the autosomal recessive form of primary immunodeficiency dis-
ease (PID) in this patient, with the CARD9 germline mutation
being present in a heterozygous state in the mother. UPD is de-
fined as the inheritance of a pair of duplicated chromosomes
from a single parent, and it is associated with 2 main types of
developmental risk: the occurrence of imprinting disorders and
the inheritance of a recessive trait [30]. Some autosomal reces-
sive PIDs due to UPD have already been reported, such as
interferon γR1 deficiency (Mendelian susceptibility to myco-
bacterial disease), perforin deficiency (familial hemophagocytic
lymphohistiocytosis type 2), lysosomal trafficking regulator
deficiency (Chediak-Higashi syndrome), or T-lymphocyte–
specific protein tyrosine kinase deficiency [31–34]. Patients
with these conditions often display other clinical signs unrelated
to the mutated PID-causing gene, but due to the extent of the
UPD [31].UPD of chromosome 9 region 9q34 has already been
reported for the homozygous sea urchin retroposon family
1 mutation responsible for Leigh syndrome, a mitochondrial
subacute necrotizing encephalomyelopathy [35]. Other homozy-
gous variants of the segment of chromosome 9 that the patient
inherited from her mother may have clinical impacts that are
not immediately evident.
Among the 42 cases reported with invasive E. dermatitidis
disease, a risk factor was identified for 19, while the other 23
cases remained unexplained (Table 1) [5–13, 16–18]. These 23
patients belonged to 21 families, all from Asia. Twelve patients
came from 2 multiplex families from Japan, 3 patients were
from South Korea, 5 were from China, 1 was from Pakistan,
and 2 were from Turkey [10, 12, 17, 18, 36–40]. Consanguinity
was not reported in these families. The clinical outcome was
poor, particularly in patients with no known risk factors. In
these patients, the disease typically affected the brain and/or
liver (Table 1) [5–13, 16, 17], with onset at a median age of 19
years [range, 3–70 years]. For the patients who are known to
have an immunodeficiency disease or who are receiving
Figure 2. A–D, Histological features of the meningeal biopsy specimen. A, Hematoxylin-eosin (H-E) staining showing fungi surrounded by an epithelioid
and giant cell granuloma (original magnification ×200). B, Strong periodic acid-Schiff staining of the fungi within the granuloma (original magnification
×400). C, H-E staining revealing a huge infiltration of fungi without granuloma in another area of the biopsy sample (original magnification ×400). D, Grocott
staining of this large area of fungi (original magnification ×400).
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immunosuppressive treatment, brain involvement was only re-
ported in the patient with chronic granulomatous disease [14]
and in 5 patients with meningitis secondary to the intrathecal in-
jection of contaminated steroids [41]. E. dermatitidis has been
shown to be neurotropic in a mouse model [42]. However, the
absence of brain involvement in most of the patients with immu-
nodeficiency disease and E. dermatitidis infection suggests that
predisposing genetic factors are also required for E. dermatitidis
infection of the CNS in humans. None of the patients with a
known immunodeficiency disease had liver involvement.
Figure 3. Impact of the CARD9 R18W mutation on protein level and function. A, Immunoblot analysis of CARD9 in whole-cell extracts of HEK-293T cells
cotransfected with pcDNA3.1 V5 (C-terminally tagged), either empty or carrying the wild-type (WT) or mutant (R18W) CARD9 allele, together with a CFP
plasmid, as a transfection control. Antibodies against CARD9, V5, CFP, and GAPDH (as a loading control) were used. B, Flow cytometry analysis of CARD9 in
monocyte-derived macrophages from a control (left panel) or the patient (right panel). C, Interleukin 6 (IL-6) production by whole-blood cells, as measured by
enzyme-linked immunosorbent assay (ELISA), after 24 hours of stimulation with zymosan (5 µg/mL), heat-killed Saccharomyces cerevisiae (106 particles/
mL), heat-killed Candida albicans (106 particles/mL), heat-killed Exophiala dermatitidis (106 particles/mL), heat-killed Staphylococcus aureus (5 × 108 par-
ticles/mL), vesicular stomatitis virus (VSV), lipopolysaccharide (LPS; 100 ng/mL), and PMA plus ionomycin for 6 controls, the CARD9-heterozygous (R18W/
WT) mother, and the CARD9-homozygous (R18W/R18W) patient. Results are expressed as mean ± standard error of the mean (SEM) of 3 independent
experiments. D, Tumor necrosis factor α (TNF-α) production by monocyte-derived dendritic cells, measured by ELISA, after 24 hours of stimulation with
curdlan (25 µg/mL), zymosan (25 µg/mL), heat-killed S. cerevisiae (106 particles/mL), heat-killed C. albicans (106 particles/mL), heat-killed E. dermatitidis
(107 particles/mL and 106 particles/mL), heat-killed S. aureus (5 × 108 particles/mL), and LPS (100 ng/mL) for 7 controls and the CARD9-homozygous (R18W/
R18W) patient. Results are expressed as mean ± SEM of 4 independent experiments. E, The CARD9 R18W allele impairs downstream NF-κB activation. NF-
κB–luciferase assay in 293 HEK cells transfected with NF-κB–luciferase and pRL-SV40 vectors alone (A); with DECTIN1, SYK, and BCL10 constructs
(B); with DECTIN-1, SYK, BCL10, and CARD9 WT constructs (C); and with DECTIN-1, SYK, BCL10, and CARD9 R18W constructs (D). Cells were stimulated
or not stimulated with 25 µg/mL curdlan or 107 particles/mL E. dermatitidis. Results are representative of 2 independent experiments performed and are
expressed as mean ± SEM of the ratio between Renilla luciferase and firefly control luciferase activities adjusted to 1. *P≤ .05, **P≤ .01, and ***P≤ .001
by the Student t test. Abbreviation: RLU, relative light units.
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Mortality in the group of patients without known risk factors was
much higher than that in patients with known risk factors (91%
vs 11%).
E. spinifera infections are also very rare. To date, 29 cases of
E. spinifera infections have been reported in the literature, 3 cor-
responding to chromoblastomycosis and 26 to phaeohyphomy-
cosis [19–22]. The diseases were cutaneous for all patients, with
frequent subcutaneous and bone extension. Among the 26 pa-
tients with phaeohyphomycosis, only 3 without known immu-
nodeficiency disease had invasive infections with lymph node
involvement or positive blood culture results [13, 23, 24]. E. spi-
nifera infections reported in children without any known risk
factors usually started as subcutaneous abscesses and frequently
disseminated, with a poor outcome [19–24]. In contrast, the 23
E. spinifera infections reported in adults were usually localized
and occurred in patients with known risk factors, such as sys-
temic lupus erythematous, corticosteroid treatments, solid
organ transplant receipt, or cancer [19–22]. Patients with E. spi-
nifera–related phaeohyphomycosis were from China (n = 5),
Brazil (n = 2), India (n = 8), El Salvador (n = 1), Pakistan
(n = 1), the United States (n = 5), Argentina (n = 1), Japan
(n = 1), and France (n = 2). The 3 patients with invasive
E. spinifera disease were a 9-year-old boy from China who
developed fungemia associated with subcutaneous and bone
infections, leading to his death [13], and a 12-year-old girl
and 41-year-old woman from India and Argentina, respectively,
who had lymph node and subcutaneous infections [23, 24].
The similarity of clinical presentation between the 2 patients
reported here and the patients with idiopathic E. dermatitidis or
E. spinifera disease reported in the literature suggests that some
of these patients may have had CARD9 deficiency. Further-
more, the identification of multiplex families is also consistent
with this hypothesis [6]. The identification of CARD9 defi-
ciency in an Angolan patient homozygous for the CARD9
R18W allele and with isolated invasive E. dermatitidis disease
and in an Iranian patient homozygous for the CARD9 E323del
mutation and with recurrent invasive E. spinifera disease broad-
ens the spectrum of invasive fungal diseases known to be
Figure 4. A, Pedigree of the patient with Exophiala spinifera infection and a CARD9 mutation. Each generation is represented by a Roman numeral, and
each individual is represented by an Arabic numeral. The proband with E. spinifera infection is shown in black and indicated by an arrow. The CARD9
genotype is indicated below the individuals sequenced. B–D, Clinical and radiological features of the patient. B, Subcutaneous skin infection. C, Hyper-
fixation revealing osteomyelitis on scintigraphy. D, Computed tomography of the chest. Abbreviation: WT, wild type.
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associated with CARD9 deficiency. The previously reported pa-
tients with other CARD9 mutations displayed other invasive
fungal infections. Three patients from a consanguineous Iranian
kindred homozygous for the Q295X CARD9 allele [26], 1 Ko-
rean girl compound heterozygous for the CARD9 G72S and
R373S alleles [27], and 1 French-Canadian male patient homo-
zygous for the CARD9 Y91H allele [28] had Candida species
infections of the CNS (all had meningitis/meningoencephalitis
and 2, the Korean girl and an Iranian girl, also had brain ab-
scesses). In addition, 6 members of the Iranian kindred were re-
ported to have chronic mucocutaneous candidiasis, and 3 were
found to have superficial dermatophytosis [26]. Two related
Moroccan patients homozygous for the CARD9 R101C allele
and 15 North African patients (11 from 5 Algerian kindreds
and 4 patients from 2 Tunisian kindreds) homozygous for the
CARD9 Q289X allele developed deep dermatophytosis [25].
Finally, 4 unrelated Chinese patients, 1 with compound hetero-
zygous mutations (c.191-192insTGCT encoding L64fsX59 and
c.472C > T encoding Q158X) and 3 with the same homozygous
frameshift mutation (c.819-820insG encoding D274fsX60) were
reported to have subcutaneous phaeohyphomycosis caused by
Phialophora verrucosa [29].
The identification and characterization of 32 patients from 17
families in 8 countries and with 11 different morbid alleles indi-
cate that CARD9 deficiency is associated with invasive fungal in-
fection due to at least 4 genera (Candida species, Exophiala
species, P. verrucosa, Trichophyton species), with a tropism for
the CNS [25–29] (this report). CARD9 deficiency may thus be
associated with a specific predisposition to fungal infections of
the CNS. As an initial hypothesis, we suggest that CARD9-
deficient patients may display an impairment of fungal elimina-
tion by monocytes, macrophages, and/or microglial cells at the
blood-brain barrier [43]. On the other hand, CARD9-deficient
cells have been shown to require fungal opsonization by serum
for the efficient killing of fungi [27].The limited access of plasma
proteins to the CNS results in fungi not being opsonized, poten-
tially accounting for the impairment of fungal killing specifically
in the CNS of CARD9-deficient patients [27]. No other severe
infections have been reported in these patients, with a particular
absence of reported infections due to Aspergillus species, bacte-
ria, and parasites. It is also intriguing that the CARD9-deficient
patients identified to date, including in this report, have each dis-
played a single type of invasive fungal disease [25–29].
The diverse and expanding clinical presentations of CARD9
deficiency suggest that this protein may control multiple molec-
ular pathways in multiple cell types involved in immunity to
various fungi. Interestingly, like patients homozygous for the
R101C or Q289X allele [25], the patient homozygous for the
R18W CARD9 allele displayed impaired production of both
IL-6 by whole-blood cells and TNF-α by MDDCs in response
to stimulation with fungal ligands (heat-killed C. albicans and S.
cerevisiae, curdlan, and zymosan). In addition, whole-blood
cells and MDDCs also displayed impaired responses to E. der-
matitidis, potentially accounting for the susceptibility of
the patient. Similarly, macrophages and dendritic cells from
patients with subcutaneous phaeohyphomycosis and the
L64fsX59/Q158X or the D274fsX60 CARD9 alleles displayed
impaired IL-6, TNF-α, interleukin 1β (IL-1β), and interleukin
23 production in response to P. verrucosa stimulation [29],
and peripheral blood mononuclear cells from the patient with
Candida dubliniensis meningoencephalitis and the G72S/
R373P CARD9 alleles showed impaired IL-6 and IL-1β produc-
tion in response to C. albicans. All these CARD9 alleles are del-
eterious for at least some leukocyte and dendritic cell responses.
In addition, there seems to be a correlation between the in vitro
defect and the clinical presentation. However, we hypothesize
that CARD9 mutations confer a predisposition to infections
caused by dermatophytes, Candida species, P. verrucosa, or
Exophiala species, with the phenotype depending on the nature
and amount of the infecting fungus.
The R18W mutation affects the CARD domain of the pro-
tein, which is known to create heterodimers with the CARD do-
main of BcL10. It may therefore impair this interaction,
decreasing downstream NF-κB activation and target gene tran-
scription [44]. In particular, patients with CARD9 deficiency
have been reported to have low proportions of IL-17 T cells,
probably resulting from impaired IL-17–inducing cytokine pro-
duction [25–27, 29]. However, patient 1 (patient 2 could not be
tested) had a normal proportion of these cells, consistent with
her lack of mucocutaneous candidiasis [45–47]. Similar obser-
vations have recently been reported for another patient homo-
zygous for the Y91H CARD9 allele with recurrent C. albicans
meningoencephalitis [28]. These findings suggest that poor
IL-17 T-cell development is not an intrinsic feature, or at least
not a general feature, of human CARD9 deficiency. Finally,
there seems to be no correlation between the type of mutation
and the type of fungal disease. Indeed, we recently identified a
patient with CNS candidiasis bearing the homozygous Q289X
CARD9 mutation (Lanternier et al, unpublished data), an allele
previously identified in patients with deep dermatophytosis
[25]. Our findings indicate that CARD9 deficiency should be
considered as a possible diagnosis in children and young adults
with disseminated, isolated, unexplained Exophiala disease and in
cases of fungal infection of the CNS. More generally, this study
suggests that idiopathic invasive fungal infections should lead
to a search for underlying inborn errors of immunity [48, 49].
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